#cartcell — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #cartcell, aggregated by home.social.
-
📢 It's the last day of #WorldBloodCancerAwarenessMonth!
⚡Join us tomorrow, Oct 1 at 10:30 CET for our Impact on Blood Cancer event & find out how our projects are leveraging #RealWorldData #BigData to improve patient outcomes & improving #CARTCell capabilities.
👉 REGISTER HERE: https://link.europa.eu/hdYgBh -
🩸 From mining #BigData to advancing #CarTCell therapies, IMI and IHI projects are working hard to improve the lives of people living with #BloodCancers like leukaemia.
👉 Find out more about their achievements and plans at our online event on 1 October - sign up now at https://europa.eu/!hdYgBh
-
🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering important results for patients.
👩💻 Join us online on 1 October, 10:30–12:00 CET for “Impact on Blood Cancers” and find out more!
👩🔬 Featuring leading experts from the HARMONY Alliance Foundation, T2EVOLVE & EASYGEN Consortium
🎟️ Register now 👉 https://europa.eu/!hdYgBh#BloodCancer #BigDataInHealth #IHITransformingHealth #CellTherapy
-
🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering results.
👩💻 Join us online on 1 Oct 10:30–12:00 CET & find out more!
https://europa.eu/!hdYgBh
#BigDataInHealth #IHITransformingHealth -
"Leo Ferreira, Ph.D., assistant professor at MUSC, discusses his research presented in his AACR poster "Repurposing chimeric antigen receptor regulatory T cells for treating cancer." #yt
https://invidious.nerdvpn.de/watch?v=OngSJR9MHZ0
Bckp.:
-
'Remission rates for patients with some forms of blood cancers treated with CAR T-cell therapy can exceed 80 per cent. But it is certainly not a miracle treatment for all forms of cancer. Biology is messy, the quality of cell therapies variable and the treatment does not work on all patients. And, despite its life-saving promise, cell therapy suffers one additional serious drawback: its cost. Emily’s cell therapy cost $473,000, putting it beyond the reach of all but the richest or best-insured. Thousands of patients who could be cured of various diseases are dying because of supply constraints. “Science is outstripping our ability to manufacture,” says June.'
#Immunology #Immunotherapy #CARTcell
https://www.ft.com/content/626007c4-9127-4682-9dab-154b32434029 -
BioNTech is partnering with Autolus to develop their #CARTcell program for solid tumors:
https://investors.biontech.de/news-releases/news-release-details/biontech-and-autolus-announce-strategic-car-t-cell-therapy
#Immunology #Immunotherapy
The target antigen of BioNTech SE's BNT211 CART is Claudin-6. I wrote about this in 2022 👇 -
https://www.nature.com/articles/d41586-023-03968-6
wow.
"Engineered immune cells have given 15 people with once-debilitating autoimmune disorders a new lease on life, free from fresh symptoms or treatments…the approach — called #CARTCell therapy — might one day be extended to a variety of other conditions fueled by rogue #immune cells that produce antibodies against the body’s own tissues.All 15 participants, who each had one of three autoimmune conditions, have remained disease-free or nearly so since their treatment…"
-
#CARTcell #therapy is a promising #immunebased #treatment approach. Explore how #scientists at #StJude are working to optimize #CARTCellTherapy to better meet all #cancer patients' needs. http://bit.ly/3Lnw8Md #StJudeOn
-
#cancer #oncology #cartcell #cartcellrx #immunotherapy #genetherapy #celltherapy #immunology #cancercare #preventativemedicine #cellulartherapeutics #celltherapies #checkpointinhibitors #patientcare #patientcenteredcare #patients #support #patientsupport #advocacy #coronavirus #COVID19 #pandemic #COVID #sars_cov_2 #covid19research #pandemic2020 #SARSCoV2 #coronavirus #Corona #pandemia #cancer #oncology